Position in LLY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$28,072,660
+$6,433,232 QoQ
Shares Held
23,405
-0.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.34%
of 13F equity value
Holder Rank
#742
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 1%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITY HOLDING CO holds $54,117,792 across 11 Drug Manufacturers - General names. LLY ranks #1 (51.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
23,405 | $28,072,660 | |
| 2 | ABBV |
AbbVie Inc.
|
43,975 | $11,065,869 | |
| 3 | JNJ |
Johnson & Johnson
|
29,051 | $7,378,082 | |
| 4 | AMGN |
Amgen Inc
|
12,282 | $4,447,557 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,085 | $1,424,422 | |
| 6 | PFE |
Pfizer Inc
|
35,409 | $852,648 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
14,061 | $810,194 | |
| 8 | NVS |
Novartis AG
|
190 | $29,776 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,072,660 | 23,405 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $21,639,428 | 23,527 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $25,748,260 | 23,959 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $17,951,864 | 23,528 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $18,188,773 | 23,333 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $19,227,184 | 23,280 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $18,288,680 | 23,690 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $22,175,963 | 25,031 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $24,063,189 | 26,578 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $21,362,781 | 27,460 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $16,947,233 | 29,073 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $16,087,043 | 29,950 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $15,221,214 | 32,456 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $11,442,754 | 33,320 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $12,616,724 | 34,487 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $11,480,217 | 35,504 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $12,261,729 | 37,818 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $11,382,347 | 39,747 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $10,985,821 | 39,772 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $9,134,561 | 39,535 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $9,078,663 | 39,555 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $7,262,253 | 38,873 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $6,500,340 | 38,500 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $5,410,871 | 36,555 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $5,966,301 | 36,340 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $4,926,363 | 35,513 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||